Insider trading

Period: 120 months Stock: ADPT Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

222 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

222 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

222 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

222 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
222 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
222 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

222 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
25 Jun 2026
Sold on a plan
$1.05M 52,084 at 20.18
76.9%
Sold half or more
3 Mar 2026
Sold on a plan
$735.07K 48,044 at 15.30
75.7%
Sold half or more
21 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$5.22M 308,477 at 16.91
51.0%
Sold half or more
20 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$4.93M 297,925 at 16.54
50.1%
Sold half or more
13 Mar 2025
Sold at will
$260.93K 36,291 at 7.19
70.2%
Sold half or more
22 Dec 2021
Taylor Stacy L SVP and General Counsel
Sold, plan not stated
$460.14K 15,338 at 30.00
50.5%
Sold half or more
27 Aug 2021
Sold, plan not stated
$522.06K 14,916 at 35.00
90.8%
Sold half or more
14 Jul 2021
Sold, plan not stated
$92.00K 2,500 at 36.80
62.4%
Sold half or more
17 Jun 2021
Sold, plan not stated
$160.00K 4,000 at 40.00
72.7%
Sold half or more
14 Jun 2021
Sold, plan not stated
$96.40K 2,500 at 38.56
62.4%
Sold half or more
18 May 2021
Sold, plan not stated
$87.50K 2,500 at 35.00
62.4%
Sold half or more
14 Apr 2021
Sold, plan not stated
$195.35K 4,500 at 43.41
75.0%
Sold half or more
18 Mar 2021
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx
Sold, plan not stated 3×
$699.56K 16,052 at 43.58
63.7%
Sold half or more
15 Mar 2021
Sold, plan not stated 2×
$187.86K 4,500 at 41.75
75.0%
Sold half or more
8 Mar 2021
HERSHBERG ROBERT Director
Sold, plan not stated 2×
$178.24K 4,000 at 44.56
100%
Sold half or more
1 Mar 2021
Sold, plan not stated
$1.16M 20,000 at 57.80
100%
Sold half or more
1 Mar 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$874.74K 15,000 at 58.32
100%
Sold half or more
1 Mar 2021
BENZENO SHARON Chief Business Development Off
Sold, plan not stated 2×
$390.14K 6,771 at 57.62
100%
Sold half or more
26 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated
$843.45K 15,000 at 56.23
100%
Sold half or more
26 Feb 2021
Taylor Stacy L SVP and General Counsel
Sold, plan not stated 3×
$156.14K 2,812 at 55.53
68.4%
Sold half or more
25 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$824.43K 14,675 at 56.18
100%
Sold half or more
24 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 4×
$866.63K 15,000 at 57.78
100%
Sold half or more
23 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$831.79K 15,000 at 55.45
100%
Sold half or more
22 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 4×
$895.62K 15,000 at 59.71
100%
Sold half or more
19 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$934.36K 15,000 at 62.29
100%
Sold half or more
19 Feb 2021
BENZENO SHARON Chief Business Development Off
Sold, plan not stated
$25.46K 416 at 61.20
100%
Sold half or more
18 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$913.82K 15,000 at 60.92
100%
Sold half or more
17 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$930.82K 15,000 at 62.05
100%
Sold half or more
16 Feb 2021
BENZENO SHARON Chief Business Development Off
Sold, plan not stated 3×
$1.05M 16,250 at 64.64
100%
Sold half or more
16 Feb 2021
Taylor Stacy L SVP and General Counsel
Sold, plan not stated 3×
$1.05M 16,250 at 64.64
92.6%
Sold half or more
16 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$978.75K 15,000 at 65.25
100%
Sold half or more
16 Feb 2021
Sold, plan not stated
$390.48K 6,000 at 65.08
80.0%
Sold half or more
16 Feb 2021
HERSHBERG ROBERT Director
Sold, plan not stated
$130.90K 2,000 at 65.45
57.1%
Sold half or more
16 Feb 2021
LO FRANCIS Chief People Officer
Sold, plan not stated
$130.90K 2,000 at 65.45
100%
Sold half or more
12 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 4×
$989.68K 15,000 at 65.98
100%
Sold half or more
11 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$949.15K 15,000 at 63.28
100%
Sold half or more
10 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 4×
$944.41K 15,000 at 62.96
100%
Sold half or more
9 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$936.09K 15,000 at 62.41
100%
Sold half or more
8 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$931.44K 15,000 at 62.10
100%
Sold half or more
5 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$899.33K 15,000 at 59.96
100%
Sold half or more
4 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$884.76K 15,000 at 58.98
100%
Sold half or more
3 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$896.34K 15,000 at 59.76
100%
Sold half or more
3 Feb 2021
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$464.16K 7,790 at 59.58
92.0%
Sold half or more
2 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$884.81K 15,000 at 58.99
100%
Sold half or more
2 Feb 2021
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 3×
$464.65K 7,790 at 59.65
92.0%
Sold half or more
1 Feb 2021
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$833.04K 15,000 at 55.54
100%
Sold half or more
1 Feb 2021
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$434.95K 7,790 at 55.83
92.0%
Sold half or more
1 Feb 2021
BENZENO SHARON Chief Business Development Off
Sold, plan not stated 2×
$376.72K 6,770 at 55.65
100%
Sold half or more
29 Jan 2021
Cohen Chad M Chief Financial Officer
Sold, plan not stated 3×
$2.80M 50,000 at 56.03
98.0%
Sold half or more
29 Jan 2021
RUBINSTEIN JULIE President
Sold, plan not stated 3×
$844.16K 15,000 at 56.28
100%
Sold half or more
Showing 1–50 of 222. Page 1 of 5 Older →